Article Information
History
- November 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emily K. Meseck1,*,
- Ghiabe Guibinga2,
- Stephen Wang3,
- Cameron McElroy1,
- Eloise Hudry3 and
- Keith Mansfield3
- 1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- 2Novartis Institutes for BioMedical Research Biologics Center, San Diego, CA, USA
- 3Novartis Institutes for BioMedical Research, Cambridge, MA, USA
- ↵*Corresponding Author: Emily K. Meseck, Novartis Pharmaceuticals 436/4223 One Health Plaza East Hanover, NJ 07936 Telephone: 1-862-778-7667, E-mail: emily.meseck{at}novartis.com